Key Technologies for Progressing Discovery of Microbiome-Based Medicines

Area of Science:

• Microbiology
• Human Health
• Therapeutics

Background:

• The human microbiome, including "microbial dark matter," plays a crucial role in health.
• The microbiome is a promising therapeutic target for diseases such as inflammatory bowel disease, diabetes, and obesity.

Purpose of the Study:

• To review current analysis and validation methods for microbiome research.
• To propose best-practice approaches for advancing microbiome-based therapies.

Main Methods:

• Utilizing multi-omic functional analyses to generate hypotheses.
• Validating hypotheses through complex, biologically relevant experimental models.
• Integrating state-of-the-art sequencing, computational analysis, and experimental assays.

Main Results:

• Causal links between the microbiome and disease are essential for developing targeted treatments.
• Current research is illuminating the microbiome's role in human health and disease.

Conclusions:

• Establishing causation is critical for microbiome-based therapeutic development.
• Advancing microbiome research requires robust, integrated analytical and validation strategies.